Dysregulation of the miRNAs-COUP-TFII-FOXM1-CENPF axis contributes to prostate cancer metastasis, with microRNA-382 inhibiting prostate cancer cell proliferation and metastasis through targeting COUP-TFII [23-25]. Here, CENPF is linked to prostate cancer.